Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | F. Weipert, Dissertation, 2018, Technische Universiät Darmstadt | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | W. C. Brucker et al., Zurich Open Repository and Archive, University of Zurich, 2012, doi.org/10.1038/onc.2011.530 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Happold et al., Mol. Cancer Ther., Apr 2014; 13: 948 - 961 | Link | |
LN-308 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. Eisele et al., Neuro Oncology, Feb 2011; 13: 155 - 164 | Link | ||
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | plasmid | stable transfection | Metafectene | publication | N. Ullrich et al., Cancer Res., May 2015; 75: 1897 - 1907 | Link | |||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Löffek et al., Front. Oncol., 2015, 5:234; doi: 10.3389/fonc.2015.00234 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. Ansems et al., Breast Cancer Res. Treat., 2015, 149:693–703; DOI: 10.1007/s10549-015-3281-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | K. Haagenson, Dissertation, 2013, Wayne State University | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. E. Semina et al., Cancer Investigation, 2017, DOI: 10.1080/07357907.2017.1368081 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | K. K. Haagenson et al., Oncotarget, 2014, 5 (4) : 1101-1110 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | B. Ljepoja et al., Scientific Reports, 2018, 8:6927, DOI:10.1038/s41598-018-25240-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | V. Vella et al., Cells, 2019, 8, 1017, doi:10.3390/cells8091017 | Link | |
MCF7 |
Human breast fibrocystic disease cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | Y. Radestock et al., Ann. N.Y. Acad Sci. 1041:462-469 (2005). Doi: 10.1196/annals.1282.070 | ||
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MeWo |
Human skin malignant melanoma cell line | ATCC HTB-65 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. Rahaus et al., J. Gen. Virol., Nov 2003; 84: 2957 - 2967 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | P. J. Hodul et al., PLoS ONE, 2013, 8(2): e52526. doi:10.1371/journal.pone.0052526 | Link | |
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. V. Karagounis et al., British Journal of Cancer, 2016, 115: 312-321; doi: 10.1038/bjc.2016.202 | Link | |
NCI-H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. R. Cuddihy et al., Mol. Cancer Ther., Apr 2008; 7: 980 - 992 | Link | |
NCI-H157 |
Human non small cell lung carcinoma cell line | ATCC CRL-5802 | Human | respiratory system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. Kanyanda, Dissertation, 2012, University of the Western Cape | Link | |
NCI-H290 |
Human pleural malignant mesothelioma cell line | Human | unknown | cell line | plasmid | stable transfection | Metafectene | publication | S. Abe et al., Cancer Sci., 2016, 107: 1198-1205; doi: 10.1111/cas.12985 | Link | |||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | K2 Transfection System | application note | ![]() |